PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS

Allogeneic hematopoietic stem cell transplantation (HSCT) is curative treatment, albeit in a minority of patients with accelerated (AP) or blast phase (BP) chronic myeloid leukemia (CML). Imatinib (IM) has transient but significant activity in advanced phases of CML, which may permit early allograft...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Khoury, Hanna J, Kukreja, Manisha, Goldman, John M., Wang, Tao, Halter, Jorg, Arora, Mukta, Gupta, Vikas, Rizzieri, David A., George, Biju, Keating, Armand, Gale, Robert Peter, Marks, David I., McCarthy, Philip L., Woolfrey, Ann, Szer, Jeffrey, Giralt, Sergio A., Maziarz, Richard T., Cortes, Jorge, Horowitz, Mary M., Lee, Stephanie J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3896981/
https://ncbi.nlm.nih.gov/pubmed/21986636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.194
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia